13F-HR filed by Altium Capital Management LLC
Altium Capital Management LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 91 holding rows worth $180,149,551.
- Accession
- 0001420506-23-001113
- Filer
- CIK 1746382
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 91 entries on the cover page, a total value of $180,149,551 stated on the cover page (in dollars after the unit check, H1), rows summing to $180,149,551 with VALUE read as dollars as filed, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,347,088 | $17,916,270 | dollars as filed | |
| NOVOCURE LTD | G6674U908 | ORD SHS | 161,500 | $9,712,610 | dollars as filed | call |
| ADMA BIOLOGICS INC | 000899104 | COM | 2,870,000 | $9,499,700 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,132,000 | $8,150,400 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 305,000 | $7,060,750 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 185,000 | $5,427,900 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 620,000 | $5,406,400 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 150,000 | $4,621,500 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 500,000 | $4,580,000 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 91,000 | $4,559,100 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 16,000 | $4,459,040 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 270,000 | $4,212,000 | dollars as filed | |
| MYRIAD GENETICS INC | 62855J104 | COM | 180,000 | $4,181,400 | dollars as filed | |
| NEOGENOMICS INC | 64049M209 | COM NEW | 240,000 | $4,178,400 | dollars as filed | |
| AKOYA BIOSCIENCES INC COM | 00974H104 | Stock | 500,000 | $4,090,000 | dollars as filed | |
| XTANT MED HLDGS INC | 98420P308 | COM NEW | 6,227,559 | $3,970,069 | dollars as filed | |
| RESMED INC COM | 761152107 | Stock | 17,000 | $3,722,830 | dollars as filed | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 850,000 | $3,570,000 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 260,000 | $3,551,600 | dollars as filed | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 35,000 | $3,182,200 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 130,000 | $3,162,900 | dollars as filed | |
| MERSANA THERAPEUTICS INC | 59045L906 | COM | 750,100 | $3,082,911 | dollars as filed | call |
| VAREX IMAGING CORP | 92214X106 | COMMON STOCK | 165,000 | $3,001,350 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 12,500 | $2,925,875 | dollars as filed | |
| KORU MEDICAL SYSTEMS INC | 759910102 | COMMON STOCK | 685,002 | $2,890,708 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 148,000 | $2,613,680 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 155,000 | $2,569,900 | dollars as filed | |
| MIMEDX GROUP INC | 602496101 | COM | 748,000 | $2,550,680 | dollars as filed | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 225,992 | $2,237,321 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 286,000 | $2,219,360 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 9,000 | $2,092,950 | dollars as filed | |
| TG VENTURE ACQUISITION CORP | 87251T109 | COM | 200,000 | $2,070,000 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 178,000 | $2,061,240 | dollars as filed | |
| NULL | 09071M205 | NULL | 2,279,657 | $2,020,916 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 505,781 | $1,967,488 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 205,000 | $1,910,600 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 55,000 | $1,842,500 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 155,000 | $1,785,600 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 45,000 | $1,760,850 | dollars as filed | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 4,588,000 | $1,674,620 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 43,000 | $1,611,640 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 100,000 | $1,606,000 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 228,714 | $1,578,127 | dollars as filed | |
| AULT DISRUPTIVE TECHS CORP | 05150A104 | COM | 150,000 | $1,570,500 | dollars as filed | |
| CYCURION INC | 95758L107 | COM | 100,000 | $1,021,000 | dollars as filed | |
| PEPPERLIME HEALTH ACQUSTN CO | G70021103 | COM | 100,000 | $1,018,500 | dollars as filed | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 112,614 | $1,000,012 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 30,000 | $979,500 | dollars as filed | |
| FAT BRANDS INC | 30258N121 | *W EXP 07/16/202 | 227,000 | $896,650 | dollars as filed | |
| COLISEUM ACQUISITION CORP | G2263T123 | COM | 85,000 | $872,100 | dollars as filed | |
| POLISHED COM INC | 28252C117 | *W EXP 06/02/202 | 6,103,824 | $603,668 | dollars as filed | |
| INVITAE CORP | 46185L103 | COM | 409,200 | $552,420 | dollars as filed | |
| GSR II METEORA ACQUISITN COR | 36263W105 | CLASS A COM | 50,000 | $517,500 | dollars as filed | |
| OPY ACQUISITION CORP I | 671005106 | COM | 50,000 | $512,750 | dollars as filed | |
| COLOMBIER ACQUISITION CORP | 19533H108 | COM | 50,000 | $506,500 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 25,000 | $502,000 | dollars as filed | |
| DOUBLEDOWN INTERACTIVE CO LT | 25862B109 | ADS | 60,876 | $485,790 | dollars as filed | |
| CHICKEN SOUP FOR THE SOUL EN | 16842Q100 | COM | 212,164 | $424,328 | dollars as filed | |
| POLISHED COM INC | 28252C109 | CMN | 576,048 | $299,603 | dollars as filed | |
| WEARABLE DEVICES LTD | M97838110 | *W EXP 09/14/202 | 1,411,600 | $193,672 | dollars as filed | |
| Panbela Therapeutics Inc | 69833W206 | Equity | 335,324 | $148,280 | dollars as filed | |
| DIRECT DIGITAL HOLDINGS INC | 25461T113 | *W EXP 02/15/202 | 180,000 | $135,000 | dollars as filed | |
| NEXERA TECHNOLOGIES LTD | M61472110 | *W EXP 08/26/202 | 980,770 | $106,058 | dollars as filed | |
| REVELATION BIOSCIENCES INC | 76135L309 | COM NEW | 37,198 | $48,357 | dollars as filed | |
| Cingulate Inc W Exp 12/10/202 | 17248W113 | Warrant | 270,000 | $46,197 | dollars as filed | |
| INNOVATIVE EYEWEAR INC | 45791D117 | *W EXP 08/16/202 | 122,400 | $44,768 | dollars as filed | |
| BRUUSH ORAL CARE INC | 11750K120 | *W EXP 08/03/202 | 360,579 | $43,269 | dollars as filed | |
| PEPPERLIME HEALTH ACQUSTN CO | G70021111 | *W EXP 10/01/202 | 367,500 | $34,949 | dollars as filed | |
| NEXGEL INC | 65344E115 | *W EXP 12/27/202 | 225,000 | $34,875 | dollars as filed | |
| HARBOR CUSTOM DEVELOPMENT IN | 41150T124 | *W EXP 10/07/202 | 650,000 | $32,435 | dollars as filed | |
| NLS PHARMACEUTICS LTD | H57830111 | *W EXP 02/02/202 | 200,000 | $30,000 | dollars as filed | |
| ONFOLIO HOLDINGS INC | 68277K124 | *W EXP 01/02/202 | 200,000 | $28,090 | dollars as filed | |
| PROSOMNUS INC | 50535E116 | *W EXP 04/20/202 | 150,000 | $23,700 | dollars as filed | |
| CEA INDUSTRIES INC | 86887P119 | *W EXP 02/11/202 | 250,000 | $19,825 | dollars as filed | |
| LIGHTNING EMOTORS INC 11.5000EXP05/18/2025 | 53228T119 | WARR | 652,173 | $16,630 | dollars as filed | |
| HARBOR CUSTOM DEVELOPMENT IN | 41150T116 | *W EXP 05/09/202 | 600,000 | $14,460 | dollars as filed | |
| DIGITAL HEALTH ACQUISITION C | 253893119 | *W EXP 99/99/999 | 150,000 | $12,750 | dollars as filed | |
| BOA ACQUISITION CORP | g8059b119 | WT | 101,439 | $10,144 | dollars as filed | |
| NEXALIN TECHNOLOGY INC | 65345B110 | *W EXP 99/99/999 | 105,000 | $9,975 | dollars as filed | |
| TG VENTURE ACQUISITION CORP | 87251T117 | *W EXP 08/15/202 | 200,000 | $9,000 | dollars as filed | |
| MURPHY CANYON ACQUISITION CO | 626642110 | *W EXP 01/25/202 | 100,000 | $9,000 | dollars as filed | |
| CYCURION INC | 95758L115 | *W EXP 02/13/203 | 100,000 | $8,900 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 82,233 | $8,223 | dollars as filed | |
| OPY ACQUISITION CORP I | 671005114 | *W EXP 09/22/202 | 50,000 | $7,665 | dollars as filed | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W122 | *W EXP 10/23/202 | 133,333 | $4,820 | dollars as filed | |
| CHAVANT CAPITAL ACQUISITN CO | G2058L111 | *W EXP 99/99/999 | 150,000 | $4,710 | dollars as filed | |
| COLISEUM ACQUISITION CORP | G2263T107 | *W EXP 08/22/202 | 28,333 | $4,108 | dollars as filed | |
| COLOMBIER ACQUISITION CORP | 19533H116 | *W EXP 99/99/999 | 16,666 | $3,605 | dollars as filed | |
| GSR II METEORA ACQUISITN COR | 36263W121 | *W EXP 02/24/202 | 50,000 | $2,000 | dollars as filed | |
| TC BIOPHARM HOLDINGS PLC | 87807D111 | *W EXP 02/10/202 | 18,823 | $1,880 | dollars as filed | |
| Relativity Acquisition Corp | 75944B114 | Warrant | 100,000 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-001113 | this filing | 2023-05-15 | acceptance time not in the bulk data set |